Daniel L. Landry

751 total citations
19 papers, 208 citations indexed

About

Daniel L. Landry is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Daniel L. Landry has authored 19 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Daniel L. Landry's work include Streptococcal Infections and Treatments (3 papers), Central Venous Catheters and Hemodialysis (3 papers) and Ion Transport and Channel Regulation (2 papers). Daniel L. Landry is often cited by papers focused on Streptococcal Infections and Treatments (3 papers), Central Venous Catheters and Hemodialysis (3 papers) and Ion Transport and Channel Regulation (2 papers). Daniel L. Landry collaborates with scholars based in United States, Canada and United Kingdom. Daniel L. Landry's co-authors include Gregory L. Braden, Stephen Sweet, Sarah Haessler, Lewis M. Cohen, Alvin H. Moss, Rebecca J. Schmidt, Cheryl Dalton, Brian H. Nathanson, Michael J. Germain and Michael H. O’Shea and has published in prestigious journals such as Journal of the American Society of Nephrology, Anesthesiology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Daniel L. Landry

17 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Landry United States 7 113 76 62 44 31 19 208
Leonard Ebah United Kingdom 9 126 1.1× 160 2.1× 71 1.1× 36 0.8× 12 0.4× 18 296
Stefaan Claus Belgium 10 71 0.6× 168 2.2× 20 0.3× 56 1.3× 11 0.4× 17 312
L WONG United States 8 62 0.5× 33 0.4× 34 0.5× 42 1.0× 14 0.5× 12 237
Kay Tyerman United Kingdom 10 58 0.5× 116 1.5× 80 1.3× 29 0.7× 14 0.5× 20 260
Ethan A. Mezoff United States 9 52 0.5× 20 0.3× 30 0.5× 71 1.6× 23 0.7× 32 282
Marc Stranz United States 6 139 1.2× 24 0.3× 77 1.2× 22 0.5× 11 0.4× 10 280
Gabriella Bottari Italy 11 13 0.1× 64 0.8× 57 0.9× 82 1.9× 18 0.6× 42 251
Sadie van Esch Netherlands 8 178 1.6× 283 3.7× 44 0.7× 25 0.6× 11 0.4× 11 335
Daniela Pellegrini United States 5 158 1.4× 18 0.2× 36 0.6× 112 2.5× 48 1.5× 5 315
C Lagarde France 9 90 0.8× 87 1.1× 65 1.0× 26 0.6× 3 0.1× 17 217

Countries citing papers authored by Daniel L. Landry

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Landry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Landry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Landry more than expected).

Fields of papers citing papers by Daniel L. Landry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Landry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Landry. The network helps show where Daniel L. Landry may publish in the future.

Co-authorship network of co-authors of Daniel L. Landry

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Landry. A scholar is included among the top collaborators of Daniel L. Landry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Landry. Daniel L. Landry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Landry, Daniel L., et al.. (2025). Semaglutide reverses the chronic myopathy of hyperkalemic periodic paralysis: a case report. BMC Nephrology. 26(1). 179–179.
2.
Landry, Daniel L., et al.. (2024). Semaglutide (S) Completely Reverses the Severe Chronic Myopathy of Hyperkalemic Periodic Paralysis. Journal of the American Society of Nephrology. 35(10S).
3.
4.
Landry, Daniel L., et al.. (2023). Treatment of severe metformin-associated lactic acidosis with renal replacement therapy and tris-hydroxymethyl aminomethane: a case report. Journal of Medical Case Reports. 17(1). 462–462. 1 indexed citations
5.
Sam, Ramin, Laura I. Rankin, Ifeoma Ulasi, et al.. (2023). Vaccination for Patients Receiving Dialysis. Kidney Medicine. 6(3). 100775–100775. 14 indexed citations
6.
Landry, Daniel L., et al.. (2023). Gemcitabine Hemolytic Uremic Syndrome (HUS) Associated with a New Complement Factor B (CFB) Mutation Successfully Treated with Eculizumab. Journal of the American Society of Nephrology. 34(11S). 482–482. 1 indexed citations
7.
8.
Verma, Ashish, et al.. (2021). <b><i>Brevundimonas vesicularis</i></b> Peritonitis in a Chronic Peritoneal Dialysis Patient. Case Reports in Nephrology and Dialysis. 11(3). 314–320. 2 indexed citations
9.
Landry, Daniel L., et al.. (2019). Continuous cefazolin infusion versus cefazolin plus probenecid for the ambulatory treatment of uncomplicated cellulitis: A retrospective cohort study. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 4(2). 108–112. 1 indexed citations
10.
Versporten, Ann, Jeannette Comeau, Charles Frenette, et al.. (2019). 1135. The 2018 Global Point Prevalence Survey of Antimicrobial Consumption and Resistance: Pediatric Results from 26 Canadian Hospitals. Open Forum Infectious Diseases. 6(Supplement_2). S404–S404. 3 indexed citations
11.
Landry, Daniel L., et al.. (2018). Oxcarbazepine Therapy for Complete Central Diabetes Insipidus. Case Reports in Nephrology and Dialysis. 8(1). 20–24. 4 indexed citations
12.
Schmidt, Rebecca J., Daniel L. Landry, Lewis M. Cohen, et al.. (2018). Derivation and validation of a prognostic model to predict mortality in patients with advanced chronic kidney disease. Nephrology Dialysis Transplantation. 34(9). 1517–1525. 25 indexed citations
13.
Landry, Daniel L., et al.. (2017). Hypercalcemia in Lung Cancer due to Simultaneously Elevated PTHrP and Ectopic Calcitriol Production: First Case Report. Case Reports in Oncological Medicine. 2017(1). 2583217–2583217. 10 indexed citations
14.
Landry, Daniel L., et al.. (2015). Effects of Prolonged Ethanol Lock Exposure to Carbothane- and Silicone-based Hemodialysis Catheters: A 26-week Study. The Journal of Vascular Access. 16(5). 367–371. 10 indexed citations
15.
Landry, Daniel L., et al.. (2013). HIV induced rhabdomyolysis. 1 indexed citations
16.
Hernández-Montfort, Jaime, et al.. (2012). Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report. Journal of Medical Case Reports. 6(1). 89–89. 10 indexed citations
17.
Landry, Daniel L., et al.. (2010). Emergence of Gentamicin-Resistant Bacteremia in Hemodialysis Patients Receiving Gentamicin Lock Catheter Prophylaxis. Clinical Journal of the American Society of Nephrology. 5(10). 1799–1804. 112 indexed citations
18.
Braden, Gregory L., et al.. (2009). Long-term gentamicin lock catheter prophylaxis is associated with gentamicin-resistant gram-positive bacteremias in chronic hemodialysis patients. 1 indexed citations
19.
Blaise, G., Serge Cournoyer, Marie‐Josée Bédard, et al.. (1991). A SPINAL CATHETER DOES NOT REDUCE POST-SPINAL HEADACHE AFTER CEASAREAN SECTION. Anesthesiology. 75(3). A857–A857. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard Ebah Breakdown of academic impact, for papers by Stefaan Claus Breakdown of academic impact, for papers by L WONG Breakdown of academic impact, for papers by Kay Tyerman Breakdown of academic impact, for papers by Ethan A. Mezoff Breakdown of academic impact, for papers by Marc Stranz Breakdown of academic impact, for papers by Gabriella Bottari Breakdown of academic impact, for papers by Sadie van Esch Breakdown of academic impact, for papers by Daniela Pellegrini Breakdown of academic impact, for papers by C Lagarde
Rankless by CCL
2026